secwatch.observer — SEC 8-K summary
======================================

Issuer:     Aterian, Inc. (ATER)
CIK:        0001757715
Form:       8-K
Filed at:   2022-10-04T23:59:59+00:00
Accession:  0001193125-22-257638
Event type: other_material
Sentiment:  negative
Materiality: 0.75
Item codes: 1.01, 2.02, 2.06, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Aterian prelim Q3 rev $63-67M, expects $24-29M goodwill impairment, closes $20M direct offering
--------------------------------------------------------------------------------

- Preliminary Q3 net revenue $63M-$67M; net loss expected due to operating loss and $24M-$29M non-cash goodwill impairment.
- Goodwill impairment charge $24M-$29M due to stock price decline and reduced market cap; previous similar charge $29M in Q1 2022.
- Closed registered direct offering of 10.64M shares + warrants for net ~$19.9M; priced at $1.90/unit for investors, $2.10 for insiders.
- Resuming M&A strategy; intends to acquire a health & wellness brand, expected to be accretive without additional headcount.
- Insider participation: CEO Yaniv Sarig, CFO Arturo Rodriguez, CLO Joe Risico, CTO Roi Zahut purchased units at $2.10 each.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1757715/000119312522257638/0001193125-22-257638-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1757715/000119312522257638/d254751d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-22-257638

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer